Lv4
510 积分 2024-07-25 加入
CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer
14天前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
27天前
已完结
Update on immunotherapy in the management of gallbladder cancer
1个月前
已完结
Case Report: Durable Complete Response After Combined Immunotherapy Following Resection of Primary Tumor in a Gallbladder Cancer Patient With Distant Metastatic Lymph Nodes of Favorable Immune-Microenvironment
1个月前
已关闭
Dynamic urinary proteomics integrates single-cell and spatial transcriptomics to reveal tumour microenvironment and predict immunotherapy response in biliary tract cancer
1个月前
已完结
Multi-omic analysis of gallbladder cancer identifies distinct tumor microenvironments associated with disease progression
1个月前
已完结
Mapping of the T-cell Landscape of Biliary Tract Cancer Unravels Anatomic Subtype-Specific Heterogeneity
1个月前
已完结
Dynamic urinary proteomics integrates single-cell and spatial transcriptomics to reveal tumour microenvironment and predict immunotherapy response in biliary tract cancer
1个月前
已完结
Multi-omic analysis of gallbladder cancer identifies distinct tumor microenvironments associated with disease progression
1个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
4个月前
已完结
皖公网安备34019202002308
